心內膜切片檢查市場規模、佔有率和成長分析：按產品類型、手術類型、引導方法、適應症、最終用戶和地區分類－2026-2033年產業預測

2024 年全球心內膜切片檢查市場價值為 4.325 億美元，預計到 2033 年將成長至 7.6231 億美元，而 2025 年為 4.6061 億美元，預測期（2026-2033 年）複合年成長率為 6.5%。

全球心內膜切片檢查(EMB) 市場正經歷顯著成長，這主要得益於移植手術數量的增加和心肌炎發生率的上升。 EMB 作為診斷心臟移植術後排斥反應和發炎性心肌病的黃金標準，至關重要，其組織學分析結果直接影響治療策略。該領域已從傳統的螢光透視法方法發展到整合分子診斷的先進影像引導技術，從而提高了安全性和診斷準確性。微型切片檢查儀器和即時心內成像等創新技術對於早期發現無症狀性排斥反應和藥物性心肌炎至關重要，有助於及時干預並改善患者預後。這個不斷擴大的市場還涵蓋醫療設備銷售、檢測服務和軟體分析，並推動了對培訓和報銷計劃的策略性投資，尤其是在新興市場。

全球心內膜切片檢查市場的成長要素

心內膜切片檢查在為複雜心臟疾病提供明確的組織學診斷方面發揮著至關重要的作用，這導致全球需求不斷成長，並進而推動了切片檢查設備及相關服務的使用量增加。臨床醫生依靠組織病理學評估來製定個人化的治療方案和管理計劃，這對於區分類似的心肌病和發炎性疾病至關重要。隨著診斷準確性在醫療保健體系中變得日益重要，醫療機構正致力於提高切片檢查技術的可近性。這一趨勢正在推動醫療機構加強對培訓、基礎設施建設以及先進醫療設備投入，尤其是在那些專門治療複雜心臟疾病的醫療機構中。

全球心內膜切片檢查市場的限制因素

由於人們對心內膜切片手術的風險和潛在併發症存在擔憂，全球心內膜切片檢查市場面臨許多限制。這些擔憂阻礙了臨床醫生和尋求非侵入性替代方案的患者更廣泛地接受這項技術。對出血、心律不整和心肌損傷等不良後果的擔憂導致轉診意願降低，並抑制了該檢查的普及，尤其是在缺乏熟練操作人員的醫療機構中。這些安全問題也影響醫療指南和報銷政策，進一步降低了該檢查的使用率。除非人們普遍對風險管理策略和適當的操作人員培訓充滿信心，否則這些擔憂將持續存在，並繼續限制市場成長和切片檢查服務在各種醫療機構中的應用。

全球心內膜切片檢查市場趨勢

全球心內膜切片檢查市場正呈現向微創手術顯著發展的趨勢，這主要得益於臨床偏好對創傷更小、更易獲取組織樣本的方法的偏好，這些方法能夠改善患者體驗。這一趨勢推動了對先進切片檢查導管、改進型影像引導系統和整合式手術平台的需求。製造商正優先考慮符合人體工學的設計，並為從業人員提供全面的培訓，以擴大這些技術在包括門診和循環系統專科在內的各種醫療機構中的應用。影像專家與醫療設備開發商之間的合作正在簡化工作流程並縮短手術時間。這也有助於促進更安全、以病人為中心的診斷流程，從而最佳化術前術後護理並提高醫療設備的可用性。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球心內膜切片檢查市場規模：依產品類型分類

• 切片檢查鉗
• Bioptomes
• 導管和導引鞘
• 影像診斷和引導系統
• 檢體採集和儲存套件
• 其他

全球心內膜切片檢查市場規模：依手術類型分類

• 右心室膜切片檢查
• 左心室膜切片檢查
• 雙心室心內膜切片檢查

全球心內膜切片檢查市場規模：依引導方法分類

• 螢光透視引導下切片檢查
• 超音波心動圖引導下切片檢查
• 磁振造影引導切片檢查
• 其他

全球心內膜切片檢查市場規模：依適應症分類

• 心臟移植術後排斥反應的監測
• 心肌炎的診斷
• 心肌病評估
• 心臟類澱粉沉積症的評估
• 侵襲性和發炎性心臟疾病的診斷
• 其他

全球心內膜切片檢查市場規模：按最終用戶分類

• 醫院
• 心臟醫療中心
• 移植中心
• 其他

全球心內膜切片檢查市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Argon Medical Devices, Inc.
• Cordis
• Mermaid Medical A/S
• Terumo Corporation
• Scholten Surgical Instruments, Inc.
• Changzhou Lookmed Medical Instrument Co., Ltd.
• Fehling Instruments GmbH & Co. KG
• Medtronic plc
• Boston Scientific Corporation
• Teleflex Incorporated
• Cook Medical LLC
• Merit Medical Systems, Inc.
• Olympus Corporation
• Integer Holdings Corporation
• B. Braun SE
• Biotronik SE & Co. KG
• Edwards Lifesciences Corporation
• Abbott Laboratories
• Lepu Medical Technology Co., Ltd.
• Oscor Inc.

結論與建議

Global Endomyocardial Biopsy Market size was valued at USD 432.5 Million in 2024 and is poised to grow from USD 460.61 Million in 2025 to USD 762.31 Million by 2033, growing at a CAGR of 6.5% during the forecast period (2026-2033).

The global endomyocardial biopsy (EMB) market is experiencing significant growth, fueled by increased transplant procedures and the rising prevalence of myocarditis. EMB remains essential as the diagnostic gold standard for assessing heart transplant rejection and inflammatory cardiomyopathies, with histological analysis directly influencing treatment strategies. This sector has evolved from traditional, fluoroscopy-dependent methods to advanced, image-guided techniques that integrate molecular diagnostics, enhancing both safety and diagnostic precision. Innovations such as smaller bioptomes and real-time intracardiac imaging are vital for early detection of subclinical rejection and drug-induced myocarditis, leading to timely interventions and improved patient outcomes. The expanding market further encompasses device sales, laboratory services, and software analytics, prompting strategic investments in training and reimbursement initiatives, particularly in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endomyocardial Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endomyocardial Biopsy Market Segments Analysis

Global endomyocardial biopsy market is segmented by product type, procedure type, guidance modality, indication, end user and region. Based on product type, the market is segmented into Biopsy Forceps, Bioptomes, Catheters & Introducer Sheaths, Imaging & Guidance Systems, Sample Collection and Preservation Kits and Others. Based on procedure type, the market is segmented into Right Ventricular Endomyocardial Biopsy, Left Ventricular Endomyocardial Biopsy and Biventricular Endomyocardial Biopsy. Based on guidance modality, the market is segmented into Fluoroscopy-Guided Biopsy, Echocardiography-Guided Biopsy, MRI-Guided Biopsy and Others. Based on indication, the market is segmented into Heart Transplant Rejection Monitoring, Myocarditis Diagnosis, Cardiomyopathy Evaluation, Cardiac Amyloidosis Assessment, Infiltrative & Inflammatory Heart Disease Diagnosis and Others. Based on end user, the market is segmented into Hospitals, Cardiac Specialty Centers, Transplant Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endomyocardial Biopsy Market

The global demand for endomyocardial biopsy is on the rise due to its key role in delivering definitive tissue diagnoses for complex cardiac ailments, leading to increased utilization of biopsy devices and related services. Clinicians depend on histopathological assessments to inform tailored treatment approaches and management plans, which are critical for distinguishing between similar cardiomyopathies and inflammatory conditions. As the emphasis on diagnostic precision grows within healthcare frameworks, providers focus on enhancing access to biopsy procedures. This trend promotes investments in training, infrastructure, and the adoption of advanced devices in medical facilities that specialize in managing intricate cardiac diseases.

Restraints in the Global Endomyocardial Biopsy Market

The global endomyocardial biopsy market faces significant constraints due to perceived procedural risks and potential complications, which hinder its wider acceptance among both clinicians and patients inclined toward noninvasive alternatives. Concerns regarding outcomes such as bleeding, arrhythmias, and myocardial damage contribute to reluctance in referral practices and inhibit adoption, particularly in facilities where skilled operators are not readily available. These safety issues also impact institutional guidelines and reimbursement attitudes, further diminishing procedural uptake. Without widespread confidence in risk management strategies and adequate operator training, these concerns will persist, limiting market growth and the incorporation of biopsy services in various healthcare environments.

Market Trends of the Global Endomyocardial Biopsy Market

The Global Endomyocardial Biopsy market is experiencing a notable trend towards minimally invasive procedures, significantly influenced by evolving clinical preferences for less intrusive tissue sampling methods that enhance patient experiences. This shift is propelling demand for advanced biopsy catheters, improved imaging guidance systems, and integrated procedural platforms. Manufacturers are prioritizing ergonomic designs and providing comprehensive training for operators to broaden the use of these techniques in various healthcare settings, including ambulatory and cardiology clinics. Collaboration among imaging specialists and device developers is fostering greater workflow efficiency, reducing procedure times, and promoting acceptance of safer, patient-centric diagnostic pathways, thus optimizing peri-procedural care and device availability.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Endomyocardial Biopsy Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Biopsy Forceps
• Bioptomes
• Catheters & Introducer Sheaths
• Imaging & Guidance Systems
• Sample Collection and Preservation Kits
• Others

Global Endomyocardial Biopsy Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Right Ventricular Endomyocardial Biopsy
• Left Ventricular Endomyocardial Biopsy
• Biventricular Endomyocardial Biopsy

Global Endomyocardial Biopsy Market Size by Guidance Modality & CAGR (2026-2033)

• Market Overview
• Fluoroscopy-Guided Biopsy
• Echocardiography-Guided Biopsy
• MRI-Guided Biopsy
• Others

Global Endomyocardial Biopsy Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Heart Transplant Rejection Monitoring
• Myocarditis Diagnosis
• Cardiomyopathy Evaluation
• Cardiac Amyloidosis Assessment
• Infiltrative & Inflammatory Heart Disease Diagnosis
• Others

Global Endomyocardial Biopsy Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Specialty Centers
• Transplant Centers
• Others

Global Endomyocardial Biopsy Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure Type, Guidance Modality, Indication, End User)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Guidance Modality, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Guidance Modality, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Guidance Modality, Indication, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Guidance Modality, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Argon Medical Devices, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mermaid Medical A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scholten Surgical Instruments, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Changzhou Lookmed Medical Instrument Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fehling Instruments GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oscor Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations